Schultz J J, Hsu A K, Gross G J
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
J Mol Cell Cardiol. 1997 Aug;29(8):2187-95. doi: 10.1006/jmcc.1997.0454.
Several investigators have demonstrated that the opioid pathway is involved in tissue preservation during hypoxia or ischemia and that this protection is mediated via the delta (delta)-opioid receptor. Subsequently, we have shown that opioid receptors are involved in ischemic preconditioning (PC) in the rat heart and that morphine produces a cardioprotective effect; however, the class of opioid receptors involved in mediating these effects is still unknown. Therefore, the purpose of the present study was to test the hypothesis that ischemia- and morphine-induced cardioprotection are mediated via stimulation of the delta-opioid receptor in the rat heart. Anesthetized, open-chest Wistar rats were subjected to one of six protocols. The control group was subjected to 30 min of occlusion and 2 h of reperfusion. Ischemic PC was elicited by three 5 min occlusion periods interspersed with 5 min of reperfusion. Morphine-induced cardioprotection was produced by three 5 min morphine infusions (100 microg/kg/infusion, i.v.) interspersed with a 5-min drug-free period. To determine if the delta-opioid receptor has a role in ischemic PC and morphine-induced cardioprotection, naltrindole (NTI), a selective delta-opioid receptor antagonist, was utilized. NTI (5 mg/kg, i.v.) was given 10 min prior to ischemic PC (NTI+PC) or morphine infusion (NTI+MOR). Also, NTI (5 mg/kg, i.v.) was given 10 min before the 30 min occlusion period in untreated rats. Infarct size (IS) as a percent of the area at risk (AAR) was determined by 2,3,5-triphenyltetrazolium chloride staining. Ischemic PC and morphine infusions resulted in similar reductions in IS/AAR from 51+/-4 to 11+/-3 and 15+/-4% (*P<0.05), respectively. NTI completely abolished the cardioprotective effect induced by ischemia and morphine. The results of the present study suggests a role of delta;-opioid receptors in ischemic PC or morphine-induced myocardial protection in the rat.
几位研究者已证明,阿片类物质通路参与缺氧或缺血期间的组织保护,且这种保护是通过δ-阿片受体介导的。随后,我们已表明阿片受体参与大鼠心脏的缺血预处理(PC),且吗啡具有心脏保护作用;然而,介导这些效应的阿片受体类别仍不清楚。因此,本研究的目的是检验以下假设:缺血和吗啡诱导的心脏保护是通过刺激大鼠心脏中的δ-阿片受体介导的。将麻醉的、开胸的Wistar大鼠分为六个方案之一。对照组经历30分钟的闭塞和2小时的再灌注。缺血预处理通过三个5分钟的闭塞期并穿插5分钟的再灌注来诱导。吗啡诱导的心脏保护通过三个5分钟的吗啡输注(100微克/千克/输注,静脉注射)并穿插5分钟的无药期来产生。为了确定δ-阿片受体在缺血预处理和吗啡诱导的心脏保护中是否起作用,使用了选择性δ-阿片受体拮抗剂纳曲吲哚(NTI)。在缺血预处理(NTI+PC)或吗啡输注(NTI+MOR)前10分钟给予NTI(5毫克/千克,静脉注射)。此外,在未处理的大鼠的30分钟闭塞期前10分钟给予NTI(5毫克/千克,静脉注射)。通过2,3,5-三苯基氯化四氮唑染色确定梗死面积(IS)占危险面积(AAR)的百分比。缺血预处理和吗啡输注分别使IS/AAR从51±4%降至11±3%和15±4%(*P<0.05),降低程度相似。NTI完全消除了缺血和吗啡诱导的心脏保护作用。本研究结果表明δ-阿片受体在大鼠缺血预处理或吗啡诱导的心肌保护中起作用。